Eric Yecies - LifeMD Preferred Gen Officer
| LFMDP Preferred Stock | USD 22.70 0.33 1.48% |
Insider
Eric Yecies is Gen Officer of LifeMD Preferred Series
| Age | 45 |
| Phone | 866 351 5907 |
| Web | https://www.lifemd.com |
Eric Yecies Latest Insider Activity
Tracking and analyzing the buying and selling activities of Eric Yecies against LifeMD Preferred preferred stock is an integral part of due diligence when investing in LifeMD Preferred. Eric Yecies insider activity provides valuable insight into whether LifeMD Preferred is net buyers or sellers over its current business cycle. Note, LifeMD Preferred insiders must abide by specific rules, including filing SEC forms every time they buy or sell LifeMD Preferred'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Eric Yecies over three months ago Disposition of 12500 shares by Eric Yecies of LifeMD subject to Rule 16b-3 | ||
Eric Yecies over three months ago Acquisition by Eric Yecies of 56250 shares of LifeMD subject to Rule 16b-3 | ||
Eric Yecies over a year ago Acquisition by Eric Yecies of 150000 shares of LifeMD subject to Rule 16b-3 |
LifeMD Preferred Management Efficiency
The company has return on total asset (ROA) of (1.169) % which means that it has lost $1.169 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (44.0716) %, meaning that it generated substantial loss on money invested by shareholders. LifeMD Preferred's management efficiency ratios could be used to measure how well LifeMD Preferred manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| David Noble | Star Equity Holdings | 52 | |
| Robert Rosen | FAT Brands | 57 | |
| Teffiny Bagnara | Cadiz Depositary Shares | N/A | |
| Matthew Molchan | Star Equity Holdings | 56 | |
| David Jin | Fortress Biotech Pref | 33 | |
| Jeffrey Eberwein | Star Equity Holdings | 53 | |
| CFA CFA | FAT Brands | 64 | |
| Ron Roe | FAT Brands | 46 | |
| Samuel Berry | Fortress Biotech Pref | N/A | |
| Stanley Speer | Cadiz Depositary Shares | 62 | |
| Susan Kennedy | Cadiz Depositary Shares | 62 | |
| Courtney Degener | Cadiz Depositary Shares | N/A | |
| Allen JD | FAT Brands | 58 | |
| Gregg Nettleton | FAT Brands | 67 | |
| Bob Halbert | Star Equity Holdings | N/A | |
| Lesley Thornburg | Cadiz Depositary Shares | N/A | |
| Michael Esq | Fortress Biotech Pref | 57 | |
| Donald Berchtold | FAT Brands | 77 | |
| Thatcher Butcher | Star Equity Holdings | N/A | |
| Hannah Bible | Star Equity Holdings | 43 | |
| Richard Coleman | Star Equity Holdings | 67 | |
Management Performance
| Return On Equity | -44.07 | ||||
| Return On Asset | -1.17 |
LifeMD Preferred Series Leadership Team
Elected by the shareholders, the LifeMD Preferred's board of directors comprises two types of representatives: LifeMD Preferred inside directors who are chosen from within the company, and outside directors, selected externally and held independent of LifeMD. The board's role is to monitor LifeMD Preferred's management team and ensure that shareholders' interests are well served. LifeMD Preferred's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, LifeMD Preferred's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alexander Mironov, President | ||
| Dennis Wijnker, Chief Officer | ||
| Brad Roberts, Chief Officer | ||
| Tameca Brown, VP HR | ||
| Marc Benathen, Chief Officer | ||
| Justin Schreiber, Chairman CEO | ||
| Nicholas Alvarez, Chief Acquisition | ||
| Eric Yecies, Gen Officer | ||
| Maria CPA, Controller Officer | ||
| Stefan Galluppi, Chief Director |
LifeMD Preferred Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right preferred stock is not an easy task. Is LifeMD Preferred a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -44.07 | ||||
| Return On Asset | -1.17 | ||||
| Profit Margin | (0.44) % | ||||
| Operating Margin | (0.39) % | ||||
| Current Valuation | 638.22 M | ||||
| Shares Owned By Institutions | 0.56 % | ||||
| Number Of Shares Shorted | 3.67 K | ||||
| Revenue | 92.88 M | ||||
| Gross Profit | 74.88 M | ||||
| EBITDA | (63.04 M) |
Pair Trading with LifeMD Preferred
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if LifeMD Preferred position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LifeMD Preferred will appreciate offsetting losses from the drop in the long position's value.Moving together with LifeMD Preferred Stock
Moving against LifeMD Preferred Stock
| 0.72 | KDLYW | Kindly MD, Warrants | PairCorr |
| 0.63 | EMMA | Emmaus Life Sciences | PairCorr |
| 0.61 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.55 | DWTX | Dogwood Therapeutics, Symbol Change | PairCorr |
| 0.52 | VSEEW | VSee Health, Symbol Change | PairCorr |
The ability to find closely correlated positions to LifeMD Preferred could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace LifeMD Preferred when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back LifeMD Preferred - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling LifeMD Preferred Series to buy it.
The correlation of LifeMD Preferred is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as LifeMD Preferred moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if LifeMD Preferred Series moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for LifeMD Preferred can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for LifeMD Preferred Stock Analysis
When running LifeMD Preferred's price analysis, check to measure LifeMD Preferred's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LifeMD Preferred is operating at the current time. Most of LifeMD Preferred's value examination focuses on studying past and present price action to predict the probability of LifeMD Preferred's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LifeMD Preferred's price. Additionally, you may evaluate how the addition of LifeMD Preferred to your portfolios can decrease your overall portfolio volatility.